arrow
P

Piazza, Francesco

university of padua school of medicine
H指数:0
被引数:4

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

From variant detection to interpretation in idiopathic erythrocytosis: A structured approach applied to a clinical cohort

从变异检测到解释在特发性红细胞增多症中的应用:应用于临床队列的结构化方法

2026-06-120
OAAI
Renal dysfunction in symptomatic Waldenström macroglobulinaemia: A nationwide Italian multicentre study

症状性华氏巨球蛋白血症的肾功能不全:一项意大利全国多中心研究

2026-03-080
OAAI
RAG1/2 expression in IGH-switched follicular lymphoma associated with transformation to high-grade B-cell lymphoma

IGH-switched滤泡性淋巴瘤中RAG1/2的表达与向高级别B细胞淋巴瘤转化的关系

Leukemia
IF13.4
2026-03-060
PRE
Secondary Genetic Events and Their Relationship to TP53 Mutation in Mantle Cell Lymphoma: A Sub-Study from the FIL_MANTLE-FIRST BIO on Behalf of Fondazione Italiana Linfomi (FIL)

次级遗传事件及其与Mantle Cell Lymphoma中TP53突变的关系:一项来自FIL_MANTLE-FIRST BIO的亚组研究,代表意大利淋巴瘤基金会(FIL)

Cancers
IF4.4
2026-03-040
OAAI
Balancing safety and efficacy of Bendamustine plus anti CD20 regimens in elderly patients (> 70 y) with follicular lymphoma: a tertiary academic center experience

平衡老年(>70岁)滤泡性淋巴瘤患者接受 Bendamustine 联合抗CD20方案的安全性与有效性:一家三级学术中心的经验

2026-02-050
OAAI
Direct-Acting Antiviral Agents in Hepatitis C-Associated Indolent Lymphomas

直接抗病毒药物在丙型肝炎相关惰性淋巴瘤中的作用

2026-01-012
PRE
The role of time to first progression and fitness status in elderly patients with mantle cell lymphoma: Results from the ELDERLY MANTLE-FIRST study

老年套细胞淋巴瘤患者中,首次进展时间和体能状态的作用:ELDERLY MANTLE-FIRST研究的结果

2025-12-010
OAAI
An Uncommon Localization of Hairy Cell Leukemia: Central Nervous System Involvement and Response to Ibrutinib—A Case Report and a Review of the Literature

毛细胞白血病的不常见定位:中枢神经系统受累及伊布替尼的治疗反应——病例报告及文献综述

2025-10-310
OAAI
Rituximab, bendamustine, and cytarabine followed by venetoclax in older patients with high-risk mantle cell lymphoma (FIL_V-RBAC): a multicentre, single-arm, phase 2 study

利妥昔单抗、 bendamustine 和 cytarabine,随后使用 venetoclax 治疗高风险套细胞淋巴瘤老年患者(FIL_V-RBAC):一项多中心、单臂、Ⅱ期研究

2025-09-170
PRE
Predictors of Splenectomy Response in Immune Thrombocytopenia: A Multicentric Italian Study
2024-12-250
OAAI
First-line treatment of Waldenstrom's macroglobulinemia in Italy: A multicenter real-life study on 547 patients to evaluate the long-term efficacy and tolerability of different chemoimmunotherapy strategies
2024-11-190
OAAI
Minimal Residual Disease Evaluation in the Context of V-Rbac, a Risk-Tailored Phase II Trial of the Fondazione Italiana Linfomi (FIL)

V-Rbac背景下微小残留病评估,一项Fondazione Italiana Linfomi (FIL)风险定制II期临床试验

BLOOD
IF23.1
2024-11-050
PRE
Baseline prognostic predictors in classical Hodgkin Lymphoma: a retrospective, single-center analysis on patients treated with PET/CT-guided ABVD

经典霍奇金淋巴瘤的基线预后预测因素: PET/CT引导下ABVD治疗患者的回顾性单中心分析

2024-09-050
OAAI
Protein kinase CK2α is overexpressed in classical hodgkin lymphoma, regulates key signaling pathways, PD-L1 and may represent a new target for therapy
2024-05-140
OAAI